venlafaxine hydrochloride

Generic: venlafaxine

Labeler: camber pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name venlafaxine hydrochloride
Generic Name venlafaxine
Labeler camber pharmaceuticals, inc.
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

venlafaxine hydrochloride 75 mg/1

Manufacturer
Camber Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 31722-124
Product ID 31722-124_495259b8-9f81-4b6e-aa51-d199aa0edfb8
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA214419
Listing Expiration 2026-12-31
Marketing Start 2020-10-23

Pharmacologic Class

Classes
norepinephrine uptake inhibitors [moa] serotonin uptake inhibitors [moa] serotonin and norepinephrine reuptake inhibitor [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 31722124
Hyphenated Format 31722-124

Supplemental Identifiers

RxCUI
808744 808748 808751 808753
UPC
0331722126908 0331722125307 0331722126304 0331722123907 0331722123303 0331722124300 0331722124904 0331722125901
UNII
7D7RX5A8MO

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name venlafaxine hydrochloride (source: ndc)
Generic Name venlafaxine (source: ndc)
Application Number ANDA214419 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 75 mg/1
source: ndc
Packaging
  • 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-124-30)
  • 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-124-90)
source: ndc

Packages (2)

31722-124-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-124-30) 31722-124-90 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-124-90)

Ingredients (1)

venlafaxine hydrochloride (75 mg/1)

Linked Drug Pages (1)

VENLAFAXINE HYDROCHLORIDE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "495259b8-9f81-4b6e-aa51-d199aa0edfb8", "openfda": {"upc": ["0331722126908", "0331722125307", "0331722126304", "0331722123907", "0331722123303", "0331722124300", "0331722124904", "0331722125901"], "unii": ["7D7RX5A8MO"], "rxcui": ["808744", "808748", "808751", "808753"], "spl_set_id": ["8c4ccc5c-f6a2-4ce3-8866-9e6b32b08fd3"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-124-30)", "package_ndc": "31722-124-30", "marketing_start_date": "20201023"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-124-90)", "package_ndc": "31722-124-90", "marketing_start_date": "20201023"}], "brand_name": "VENLAFAXINE HYDROCHLORIDE", "product_id": "31722-124_495259b8-9f81-4b6e-aa51-d199aa0edfb8", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Norepinephrine Uptake Inhibitors [MoA]", "Serotonin Uptake Inhibitors [MoA]", "Serotonin and Norepinephrine Reuptake Inhibitor [EPC]"], "product_ndc": "31722-124", "generic_name": "venlafaxine", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VENLAFAXINE HYDROCHLORIDE", "active_ingredients": [{"name": "VENLAFAXINE HYDROCHLORIDE", "strength": "75 mg/1"}], "application_number": "ANDA214419", "marketing_category": "ANDA", "marketing_start_date": "20201023", "listing_expiration_date": "20261231"}